(Q39588620)

English

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

scientific article published on April 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

anti-retroviral agent

0 references

0 references

Pneumocystis carinii

object named as

Pneumocystis carinii

1 reference

based on heuristic

inferred from title

Antonella d'Arminio Monforte

6

object named as

A d'Arminio Monforte

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

9

object named as

J D Lundgren

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

4

object named as

O Kirk

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

10

object named as

P Reiss

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

object named as

A Mocroft

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

G J Weverling

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

B Ledergerber

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J Gonzáles-Lahoz

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

R Proenca

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A N Phillips

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

353

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

9161

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1293-1298

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in use of antiretroviral therapy in regions of Europe over time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Resolution of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody response to a major humanPneumocystis carinii surface antigen in patients without evidence of immunosuppression and in patients with suspected atypical pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic responses to Pneumocystis carinii antigens in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2903287-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(99)03287-0

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39588620&oldid=1879225615"